| Literature DB >> 4016280 |
J Bonneterre, D Horner, J P Peyrat, B Vandewalle, L Cambier, A Demaille.
Abstract
The prognostic significance of estradiol (ER) and progesterone receptors (PgR) for survival from relapse has been studied in two groups of breast cancer patients: group 1, 35 patients in whom receptor levels were measured at the time of mastectomy; group II, 49 patients in whom receptor levels were measured at the time of recurrence. ER+ (greater than 10 fmoles/mg) patients had a better survival from relapse than ER- patients. High levels of PgR (greater than 50 fmoles/mg) had a prognostic significance only in group II patients.Entities:
Mesh:
Substances:
Year: 1985 PMID: 4016280 DOI: 10.1007/bf01805988
Source DB: PubMed Journal: Breast Cancer Res Treat ISSN: 0167-6806 Impact factor: 4.872